Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 3 1Phase 2 1

Status

Completed 5

Sponsor Class

INDUSTRY 5NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5Gynecologic 5Plasma cell 1Lymphoid 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 5

Interventions

Carboplatin 542Pemetrexed 392pembrolizumab 372Cisplatin 356Paclitaxel 285Docetaxel 240Gemcitabine 168Nivolumab 158Erlotinib Hydrochloride 147Bevacizumab 114atezolizumab 104osimertinib 99durvalumab 92Etoposide 90Gefitinib 68130-nm albumin-bound paclitaxel 65Cetuximab 64Ipilimumab 60Drug Therapy 51Topotecan 48Injections 44Afatinib 41tislelizumab 40Cyclophosphamide 39Albumin-Bound Paclitaxel 37Vinorelbine 36Crizotinib 34cemiplimab 31icotinib 26Radiotherapy 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × TER 286 × Thoracic × Clear all
NCT00088556 2012-05-31

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Telik

Phase 1/2 Completed
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00040638 2011-07-25

Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer

Telik

Phase 2 Completed
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00047801 2011-07-25

Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer

Telik

Phase 1/2 Completed
28 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00077883 2011-07-25

TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Telik

Phase 1/2 Completed
50 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00080340 2008-01-15

Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Telik

Phase 3 Completed
520 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡